(MedPage Today) — SAN FRANCISCO — Men with advanced prostate cancer and limited metastatic recurrence lived more than twice as long without disease progression when they received metastasis-directed radioactive therapy in addition to radiation…
Source link : https://www.medpagetoday.com/meetingcoverage/astro/117690
Author :
Publish date : 2025-09-29 15:37:00
Copyright for syndicated content belongs to the linked Source.
